CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank64
5Y CAGR-25.0%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

5Y CAGR
-25.0%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
202535.14%
2024-3.19%
2023-14.56%
2022-813.77%
2021-114.76%
2020147.62%
2019-75.82%
2018-28.63%
2017159.32%
2016-45.58%